• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药藤黄的抗肿瘤作用及机制:综述

Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review.

作者信息

Zhou Yanqing, Chen Jialing, Zhu Qin, Lin Binyan

机构信息

School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.

School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

出版信息

Front Pharmacol. 2025 Aug 18;16:1650560. doi: 10.3389/fphar.2025.1650560. eCollection 2025.

DOI:10.3389/fphar.2025.1650560
PMID:40900835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400869/
Abstract

Traditional Chinese medicine (TCM) gamboge is a dried resin obtained from Hook f. For over 500 years, TCM gamboge has been used to treat scrofula, carbuncle, jaundice, furuncle, and other chronic and stubborn diseases. An increasing amount of evidence has proven the significant anticancer properties of the main active ingredients from gamboge in recent years. The ingredients of gamboge, such as gambogic acid (GA) and gambogenic acid (GNA), can inhibit tumor growth through various processes, including apoptosis induction, cell cycle arrest, tumor cell invasion and migration inhibition, and autophagy regulation. In this review, we elaborate on the role of the main active ingredients of gamboge in treating cancers. It would be enlightening to provide the possible therapeutic applications of gamboge in the clinic.

摘要

中药藤黄是从藤黄科藤黄属植物中获取的一种干燥树脂。500多年来,中药藤黄一直用于治疗瘰疬、痈疽、黄疸、疖肿及其他慢性顽固性疾病。近年来,越来越多的证据证明藤黄主要活性成分具有显著的抗癌特性。藤黄的成分,如藤黄酸(GA)和藤黄新生酸(GNA),可通过多种过程抑制肿瘤生长,包括诱导细胞凋亡、阻滞细胞周期、抑制肿瘤细胞侵袭和迁移以及调节自噬。在本综述中,我们阐述了藤黄主要活性成分在治疗癌症中的作用。提供藤黄在临床上可能的治疗应用将具有启发性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/20ae2a7b2512/fphar-16-1650560-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/369a454741c2/fphar-16-1650560-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/7447241bdce0/fphar-16-1650560-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/20ae2a7b2512/fphar-16-1650560-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/369a454741c2/fphar-16-1650560-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/7447241bdce0/fphar-16-1650560-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d33f/12400869/20ae2a7b2512/fphar-16-1650560-g003.jpg

相似文献

1
Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review.中药藤黄的抗肿瘤作用及机制:综述
Front Pharmacol. 2025 Aug 18;16:1650560. doi: 10.3389/fphar.2025.1650560. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights.冬凌草:一种有效的抗肿瘤草药疗法——植物学、植物化学、临床应用及见解
J Ethnopharmacol. 2025 Jan 31;340:119200. doi: 10.1016/j.jep.2024.119200. Epub 2024 Dec 3.
4
Short-Term Memory Impairment短期记忆障碍
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Gambogic acid: Multi-gram scale isolation, stereochemical erosion toward epi-gambogic acid and biological profile.藤黄酸:多克级规模的分离、向表藤黄酸的立体化学转变及生物学特性
Front Nat Prod. 2022;1. doi: 10.3389/fntpr.2022.1018765.
7
Signal pathways in the treatment of Rheumatoid Arthritis with traditional Chinese medicine.中药治疗类风湿关节炎的信号通路
J Ethnopharmacol. 2025 Aug 6;353(Pt B):120387. doi: 10.1016/j.jep.2025.120387.
8
Targeting ferroptosis in the treatment of ulcerative colitis by traditional Chinese medicine: A novel therapeutic strategies.中药靶向铁死亡治疗溃疡性结肠炎:一种新的治疗策略
Phytomedicine. 2025 Apr;139:156539. doi: 10.1016/j.phymed.2025.156539. Epub 2025 Feb 17.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Gambogic Acid Induces Ferroptosis via miR-1291/FOXA2 Axis in Gastric Cancer.藤黄酸通过miR-1291/FOXA2轴诱导胃癌细胞发生铁死亡
Am J Chin Med. 2025;53(3):951-971. doi: 10.1142/S0192415X25500363.
2
An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment.一种负载藤黄酸的可注射纳米复合水凝胶通过重塑免疫抑制性肿瘤微环境增强抗肿瘤效果。
Mater Today Bio. 2025 Feb 24;31:101611. doi: 10.1016/j.mtbio.2025.101611. eCollection 2025 Apr.
3
Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
藤黄酸通过靶向 B 细胞特异性 Moloney 白血病病毒插入位点 1 来损害神经胶质瘤干细胞的维持和治疗抵抗。
Phytomedicine. 2024 Dec;135:156070. doi: 10.1016/j.phymed.2024.156070. Epub 2024 Sep 17.
4
Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential.简化型藤黄酸前药纳米颗粒以提高效率并降低毒性,具有临床转化潜力。
Adv Healthc Mater. 2024 Dec;13(31):e2401950. doi: 10.1002/adhm.202401950. Epub 2024 Sep 14.
5
Multiple Treatment of Triple-Negative Breast Cancer Through Gambogic Acid-Loaded Mesoporous Polydopamine.载姜黄素介孔聚多巴胺多重治疗三阴性乳腺癌
Small. 2024 Aug;20(31):e2309583. doi: 10.1002/smll.202309583. Epub 2024 Mar 6.
6
Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma.藤黄酸抑制胃印戒细胞癌的作用机制。
Med Oncol. 2023 Aug 16;40(9):269. doi: 10.1007/s12032-023-02149-9.
7
Pancreatic cancer: Advances and challenges.胰腺癌:进展与挑战。
Cell. 2023 Apr 13;186(8):1729-1754. doi: 10.1016/j.cell.2023.02.014.
8
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
9
Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review.早期非小细胞肺癌围手术期免疫检查点抑制:综述
JAMA Oncol. 2023 Jan 1;9(1):135-142. doi: 10.1001/jamaoncol.2022.5389.
10
A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions.简要综述了 VEGF、PDGF、FGF、Notch、血管生成素和 HGF 在肿瘤血管生成中的信号通路,并重点探讨了肿瘤血管生成的其他治疗方法和未来研究方向。
Int J Biol Macromol. 2022 Nov 30;221:1428-1438. doi: 10.1016/j.ijbiomac.2022.09.129. Epub 2022 Sep 17.